JANUS HENDERSON GROUP PLC

Holdings History for AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL)

Symbol: AVDL
Investment type: Equity / Ordinary Shares, nominal value $0.01 per share
Latest Disclosed Shares Owned: 1,823,865 shares
Security Ownership %: 1.9%

Shares, Excluding Options vs Price

Value, Excluding Options

JANUS HENDERSON GROUP PLC ownership in AVADEL PHARMACEUTICALS PLC Ordinary Shares, nominal value $0.01 per share (AVDL)

17 Feb 2026 - JANUS HENDERSON GROUP PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,823,865 shares of AVADEL PHARMACEUTICALS PLC Ordinary Shares, nominal value $0.01 per share (AVDL). This represents 1.9% ownership of the company. In their previous filing dated 14 Nov 2025, JANUS HENDERSON GROUP PLC had reported owning 7,429,718 shares, indicating a decrease of +75%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
JANUS HENDERSON GROUP PLC	1.9%	-72%	$39,176,620	1,823,865	-5,605,853	-75%	$21.48	13G/A	31 Dec 2025	17 Feb 2026, 12:34
JANUS HENDERSON GROUP PLC	7.7%	-32%	$113,451,794	7,429,718	-3,702,413	-33%	$15.27	13G/A	30 Sep 2025	14 Nov 2025, 12:07
JANUS HENDERSON GROUP PLC	12%	-19%	$108,760,920	11,132,131	-2,460,203	-18%	$9.77	13G/A	30 Jun 2025	14 Aug 2025, 11:00
JANUS HENDERSON GROUP PLC	14%	-3.3%	$119,204,769	13,592,334	-487,885	-3.5%	$8.77	13G/A	31 Mar 2025	14 May 2025, 12:00
JANUS HENDERSON GROUP PLC	15%		$123,483,521	14,080,219			$8.77	13G/A	31 Dec 2024	14 Feb 2025, 11:55

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.02%	-0.05%	$39,300,130	1,823,865	-5,605,853	-75%	$21.55	Q4 2025
30 Sep 2025	0.05%	-0.03%	$113,425,183	7,429,718	-3,702,413	-33%	$15.27	Q3 2025
30 Jun 2025	0.05%	-0.01%	$98,494,866	11,132,131	-2,460,203	-18%	$8.85	Q2 2025
31 Mar 2025	0.06%	-0%	$108,839,643	13,592,334	-487,885		$8.01	Q1 2025
31 Dec 2024	0.08%	+0%	$148,117,290	14,080,219	+753,332	+5.7%	$10.52	Q4 2024
30 Sep 2024	0.09%	+0%	$174,782,124	13,326,887	+29,570	+0.22%	$13.12	Q3 2024
30 Jun 2024	0.1%	+0.1%	$187,055,324	13,297,317	+13,297,317	NEW	$14.07	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.